SEARCH

SEARCH BY CITATION

References

  • 1
    SBU. STAN—ST waveform analysis combined with cardiotocography for fetal monitoring during childbirth. Stockholm, Sweden: SBU—The Swedish Council on Technology Assessment in Health Care; 2006 Jun. Report No.: 2006–04.
  • 2
    Amer-Wahlin I, Hellsten C, Noren H, Hagberg H, Herbst A, Kjellmer I, et al. Cardiotocography only versus cardiotocography plus ST analysis of fetal electrocardiogram for intrapartum fetal monitoring: a Swedish randomised controlled trial. Lancet 2001;358:5348.
  • 3
    Westgate J, Harris M, Curnow JS, Greene KR. Plymouth randomized trial of cardiotocogram only versus ST waveform plus cardiotocogram for intrapartum monitoring in 2400 cases. Am J Obstet Gynecol 1993;169:115160.
  • 4
    Ojala K, Vaarasmaki M, Makikallio K, Valkama M, Tekay A. A comparison of intrapartum automated fetal electrocardiography and conventional cardiotocography—a randomised controlled study. BJOG 2006;113:41923.
  • 5
    Neilson JP. Fetal electrocardiogram (ECG) for fetal monitoring during labour. Cochrane Database Syst Rev 2006;CD000116.
  • 6
    Sculpher M, Claxton K. Establishing the cost-effectiveness of new pharmaceuticals under conditions of uncertainty—when is there sufficient evidence? Value Health 2005;8:43346.
  • 7
    National Collaborating Centre for Women’s and Children’s Health (Great Britain), National Institute for Health and Clinical Excellence (Great Britain). Intrapartum Care: Care of Healthy Women and Their Babies During Childbirth. London: RCOG Press, 2007.
  • 8
    Drummond MF. Methods for the Economic Evaluation of Health Care Programmes, 3rd edn. Oxford, UK: Oxford University Press, 2005.
  • 9
    Claxton K, Sculpher M, Drummond M. A rational framework for decision making by the National Institute For Clinical Excellence (NICE). Lancet 2002;360:71115.
  • 10
    Statistics Sweden. Consumer Price Index. Örebro, Sweden: Statistics Sweden. 2007. [www.scb.se/templates/tableOrChart_33848.asp]. Accessed 15 June 2007.
  • 11
    Perlman JM. Intrapartum asphyxia and cerebral palsy: is there a link? Clin Perinatol 2006;33:33553.
  • 12
    Low JA, Lindsay BG, Derrick EJ. Threshold of metabolic acidosis associated with newborn complications. Am J Obstet Gynecol 1997;177:13914.
  • 13
    Badawi N, Felix JF, Kurinczuk JJ, Dixon G, Watson L, Keogh JM, et al. Cerebral palsy following term newborn encephalopathy: a population-based study. Dev Med Child Neurol 2005;47:2938.
  • 14
    Blair E, Watson L, Badawi N, Stanley FJ. Life expectancy among people with cerebral palsy in Western Australia. Dev Med Child Neurol 2001;43:50815.
  • 15
    Hall MH, Bewley S. Maternal mortality and mode of delivery. Lancet 1999;354:776.
  • 16
    Neilson JP. Fetal electrocardiogram (ECG) for fetal monitoring during labour. Cochrane Database Syst Rev 2003(2):CD000116.
  • 17
    The National Board of Health and Welfare. Kejsarsnitt i Sverige 1990-2001 (In Swedish). Stockholm, Sweden: National Board of Health and Welfare. 2005. Artnr: 2005-112–13. www.socialstyrelsen.se/NR/rdonlyres/3053EF38-1210-4385-A918-A65709A3A278/3463/20051123.pdf].
  • 18
    Kankuri E, Kurki T, Carlson P, Hiilesmaa V. Incidence, treatment and outcome of peripartum sepsis. Acta Obstet Gynecol Scand 2003;82:7305.
  • 19
    Östergötland County Council. Obstetrix Database, Data from Vrinnevi Hospital. Norrköping, Sweden: Östergötland County Council, 2007.
  • 20
    Van De Riet JE, Vandenbussche FP, Le Cessie S, Keirse MJ. Newborn assessment and long-term adverse outcome: a systematic review. Am J Obstet Gynecol 1999;180:10249.
  • 21
    Amer-Wahlin I, Rosen KG. A comparison of intrapartum automated fetal electrocardiography and conventional cardiotocography-assessment of outcome. BJOG 2006;113:133940; author reply 1340.
  • 22
    Hanson U. Revision av delar av STAN studien (In Swedish). Uppsala, Sweden. 2007. [http://www.dagensmedicin.se/nyheter/2007/06/19/ledareanklagelseromfuskors/revision-070530.pdf].
  • 23
    Marsal K. Bemötande av påståenden i en rapport av docent Ulf Hanson, 30 maj 2007, med titeln "Revision av delar av STAN studien" (In Swedish). Lund, Sweden: Institution for Clinical Sciences, Lund University; 2007. Report No.: RÄ 2007/167. www.dagensmedicin.se/nyheter/2007/06/19/ledareanklagelseromfuskors/Brev-till-rektor-LU.pdf].
  • 24
    Noren H, Amer-Wahlin I, Hagberg H, Herbst A, Kjellmer I, Marsal K, et al. Fetal electrocardiography in labor and neonatal outcome: data from the Swedish randomized controlled trial on intrapartum fetal monitoring. Am J Obstet Gynecol 2003;188:18392.
  • 25
    Östergötland County Council. Cost per Patient Database. Data from Vrinnevi Hospital and Linköping University Hospital. Östergötland, Sweden: Östergötland County Council, 2006.
  • 26
    Neoventa Medical AB. Price list. Mölndal, Sweden: Neoventa Medical AB, 2007.
  • 27
    Medexa Diagnostisk Service AB. Price list. Limhamn, Sweden: Medexa Diagnostisk Service AB, 2007.
  • 28
    Triolab AB. Price list. Göteborg, Sweden: Triolab AB, 2007.
  • 29
    County Councils of Östergötland Kalmar and Jönköping. Priser och ersättningar för Sydöstra sjukvårdsregionen 2006. Sweden: County Councils of Östergötland, Kalmar and Jönköping, Beslut i Regionsjukvårdsnämnden 15 December 2005. [www.lio.se/upload/16047/Prislista%202006.pdf]. Accessed 14 April 2007.
  • 30
    County Councils of Östergötland Kalmar and Jönköping. Priser och ersättningar för Sydöstra sjukvårdsregionen 2007. Sweden: County Councils of Östergötland, Kalmar and Jönköping, Beslut i Regionsjukvårdsnämnden 19 December 2006. [www.lio.se/upload/16047/Prislista%202007.pdf]. Accessed 27 May 2008.
  • 31
    Levin LA, Bergqvist D. Cost effectiveness of desirudin compared with a low molecular weight heparin in the prevention of deep vein thrombosis after total hip replacement surgery. Pharmacoeconomics 2001;19:58997.
  • 32
    Ghatnekar O, Persson U, Glader EL, Terent A. Cost of stroke in Sweden: an incidence estimate. Int J Technol Assess Health Care 2004;20:37580.
  • 33
    Svensson M, Persson U, Johansson F, Institutet för hälso- och sjukvårdsekonomi. Samhällsekonomiska kostnader för patientskador i svensk sjukvård några typfall (In Swedish). IHE RAPPORT 2004:3. Lund, Sweden: The Swedish Institute for Health Economics (IHE); August 2004.
  • 34
    Bouwes N. The Cost of Illness Handbook. Cambridge, MA: Abt Associates: 2001. III.7-7 p [www.epa.gov/oppt/coi/pubs/III_7.pdf]. Accessed 4 May 2007
  • 35
    Statistics Sweden. Sammanräknad förvärvsinkomst för boende i Sverige den 31/12 resp år (antal personer, medel- och medianinkomst samt totalsumma) efter region, kön, ålder och inkomstklass. År 1991-2005 (In Swedish). Örebro, Sweden: Statistics Sweden. [www.ssd.scb.se]. Assessed 5 June 2007.
  • 36
    Noren H, Blad S, Carlsson A, Flisberg A, Gustavsson A, Lilja H, et al. STAN in clinical practice–the outcome of 2 years of regular use in the city of Gothenburg. Am J Obstet Gynecol 2006;195:715.
  • 37
    Hanson U. Patientförsäkringens roll (In Swedish). In: Socialstyrelsen, editor. Allmänna råd från Socialstyrelsen 1994:2. Hjärnskador vid syrebrist hos fullgångna nyfödda barn. Stockholm, Sweden: Modin-Tryck; 1993. p. 71.
  • 38
    Carroll KJ. On the use and utility of the Weibull model in the analysis of survival data. Control Clin Trials 2003;24:682701.
  • 39
    Statistics Sweden. Life tables for 2006, divided into men and women. Örebro, Sweden: Statistics Sweden. [www.ssd.scb.se]. Assessed 1 August 2007.
  • 40
    Rosenbaum PL, Livingston MH, Palisano RJ, Galuppi BE, Russell DJ. Quality of life and health-related quality of life of adolescents with cerebral palsy. Dev Med Child Neurol 2007;49:51621.
  • 41
    Bax M, Tydeman C, Flodmark O. Clinical and MRI correlates of cerebral palsy: the European Cerebral Palsy Study. JAMA 2006;296:16028.
  • 42
    Burstrom K, Johannesson M, Diderichsen F. Swedish population health-related quality of life results using the EQ-5D. Qual Life Res 2001;10:62135.
  • 43
    Mutch L, Alberman E, Hagberg B, Kodama K, Perat MV. Cerebral palsy epidemiology: where are we now and where are we going? Dev Med Child Neurol 1992;34:54751.
  • 44
    Briggs AH, Goeree R, Blackhouse G, O’Brien BJ. Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med Decis Making 2002;22:290308.
  • 45
    Fenwick E, Byford S. A guide to cost-effectiveness acceptability curves. Br J Psychiatry 2005;187:1068.
  • 46
    Gold MR. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press, 1996.
  • 47
    Himmelmann K, Hagberg G, Beckung E, Hagberg B, Uvebrant P. The changing panorama of cerebral palsy in Sweden. IX. Prevalence and origin in the birth-year period 1995-1998. Acta Paediatr 2005;94:28794.
  • 48
    Badawi N, Kurinczuk JJ, Keogh JM, Alessandri LM, O’Sullivan F, Burton PR, et al. Intrapartum risk factors for newborn encephalopathy: the Western Australian case-control study. BMJ 1998;317:15548.